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We read with great interest Hallam and col-
leagues’ article regarding the beneﬁcial effects
of ultraviolet (UV) exposure in their patient-
speciﬁc in vitro model of age-related macular
degeneration (AMD) [1]. In light of recent evi-
dence proposing an active and deleterious role
of UV exposure within AMD pathogenesis [2]
their ﬁndings raise interesting questions, which
may have clinical relevance in our understanding
of the photobiological mechanisms affecting the
aging macula and pathogenesis of AMD. We are
interested in both their methodology and ﬁnd-
ings and would like to raise a number of issues.
When irradiating their model, the authors
have cited 390–410 nm as the “ultraviolet”
wavelength the tissue was exposed to. It is
worth noting that although UV-C (<280 nm)
does not reach the surface of the Earth in solar
radiation, the eye is exposed to UV-B wave-
lengths (280–315 nm) and UV-A (315–400 nm)
through ambient exposure to sunlight. However,
above 400 nm is visible light [3]. In light of this,
we would be interested to learn how this nar-
row emission band was achieved, as the authors
have not described their UV source, or how its
spectral output was gated.
Moreover, the means of quantifying the
reported irradiance of 0.0045 mW/cm2, and its
relevance as a stressor, has not been clearly out-
lined by the authors. Whether or not this inten-
sity of UV could reasonably expect to reach the
retina of the general public is left unclear, it is
important to note that the vast majority of UV
radiation that falls upon the eye is absorbed by
the cornea, lens, and vitreous humor with only a
fraction reaching the retinal basement mem-
branes [4]. It is intriguing nonetheless, that long-
wave UV decreased drusen volume in the high-
risk cells, and we agree with the authors’ state-
ment that this ﬁnding should be investigated
further to isolate the mechanism of action.
However, any broad statements, that exposure
to UV radiation is beneﬁcial to those at high risk
of AMD, should be considered carefully to
ensure they are in keeping with the best avail-
able evidence.
There is a pressing need to standardize exper-
imental models that seek to explore UV-RPE
interaction, and we should be grateful to the
authors for addressing the issues raised. This will
provide the level of detail required for others to
replicate experiments and compare datasets,
which is necessary in exploring this ﬁeld further.
It is in light of these concerns that we
kindly invite the authors to expand upon the
UV irradiance apparatus used in their manu-
script, and the steps taken to validate its use
within an in vitro context.
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